As the FDA considers removing the warning label from hormone replacement therapy for symptoms of menopause, Jen Gunter, MD, an OB/GYN and pain medicine physician and author of <a href="https://www.kensingtonbooks.com/9780806540665/the-menopause-manifesto/">The Menopause Manifesto</a> (Citadel Press, 2021) and <a href="https://www.kensingtonbooks.com/9780806540689/blood/">Blood: The Science, Medicine, and Mythology of Menstruation</a> (Citadel Press, 2024), explains the current science and when the risks outweigh the potential benefits.

As the FDA considers removing the warning label from hormone replacement therapy for symptoms of menopause, Jen Gunter, MD, an OB/GYN and pain medicine physician and author of The Menopause Manifesto (Citadel Press, 2021) and Blood: The Science, Medicine, and Mythology of Menstruation (Citadel Press, 2024), explains the current science and when the risks outweigh the potential benefits.

&nbsp;As the FDA considers removing the warning label from hormone replacement therapy for symptoms of menopause, Jen Gunter, MD, an OB/GYN and pain medicine physician and author of <a href="https://www.kensingtonbooks.com/9780806540665/the-menopause-manifesto/" rel="noopener noreferrer">The Menopause Manifesto</a> (Citadel Press, 2021) and <a href="https://www.kensingtonbooks.com/9780806540689/blood/" rel="noopener noreferrer">Blood: The Science, Medicine, and Mythology of Menstruation</a> (Citadel Press, 2024), explains the current science and when the risks outweigh the potential benefits.

HRT and the FDA

Brian Lehrer leads the conversation about what matters most now in local and national politics, our own communities and our lives.

Share HRT and the FDA

Sign up to save your podcasts

HRT and the FDA

HRT and the FDA